Impact of matching for HLA extended haplotypes
| No. of patients . | No. of EH . | Alive and well . | Acute GVHD (II-IV) . | Chronic GVHD . | Rejection . | Death . | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n . | % . | n . | % . | n . | % . | n . | % . | n . | % . | ||
| 7 | 2 | 5 | 71.4 | 0 | – | 0 | – | 1 | 14.2 | 1 | 14.2 |
| 15 | 1 | 12 | 80.0 | 6 | 46.1 | 2 | 16.6 | 1 | 6.6 | 2 | 13.3 |
| 10 | 0 | 5 | 50.0 | 5 | 62.5 | 4 | 57.1 | 2 | 20.0 | 3 | 30.0 |
| No. of patients . | No. of EH . | Alive and well . | Acute GVHD (II-IV) . | Chronic GVHD . | Rejection . | Death . | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n . | % . | n . | % . | n . | % . | n . | % . | n . | % . | ||
| 7 | 2 | 5 | 71.4 | 0 | – | 0 | – | 1 | 14.2 | 1 | 14.2 |
| 15 | 1 | 12 | 80.0 | 6 | 46.1 | 2 | 16.6 | 1 | 6.6 | 2 | 13.3 |
| 10 | 0 | 5 | 50.0 | 5 | 62.5 | 4 | 57.1 | 2 | 20.0 | 3 | 30.0 |
EH indicates extended haplotype.